日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

莫苏妥珠单抗固定疗程皮下注射治疗复发/难治性滤泡性淋巴瘤:关键性 II 期主要分析

Bartlett, Nancy L; Sehn, Laurie H; Assouline, Sarit; Giri, Pratyush; Kuruvilla, John; Schuster, Stephen J; Yoon, Sung-Soo; Fay, Keith; Hess, Georg; Dreyling, Martin; Gutierrez, Norma C; Cybulski, Eva; Sabalvaro, Fidelis; Penuel, Elicia; Teodoro, Vanda; Tracy, Samuel; Kuruvilla, Denison; Chen, Joseph; Wiebking, Volker; Wei, Michael C; Budde, L Elizabeth

Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study

莫苏妥珠单抗对复发/难治性滤泡性淋巴瘤老年患者有效且耐受性良好:一项 I/II 期研究的亚组分析

Thiruvengadam, Swetha Kambhampati; Popplewell, Leslie L; Herrera, Alex F; Mei, Matthew; Nikolaenko, Liana; Zuo, Xiaofang; Yin, Shen; Zhou, Mingzhu; Mun, Yong; Wu, Mei; Wei, Michael C; Budde, Lihua E

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial

莫苏妥珠单抗联合波拉妥珠单抗治疗不适合移植的难治性/复发性大B细胞淋巴瘤:III期SUNMO试验的主要结果

Budde, Lihua E; Zhang, Huilai; Kim, Won-Seog; Maruyama, Dai; Rego, Eduardo M; Norasetthada, Lalita; Hong, Huangming; Ozcan, Muhit; Jeon, Young-Woo; Leão Cordeiro de Farias, Danielle; Fogliatto, Laura Maria; Pavlovsky, Astrid; Goto, Hideki; Olszewski, Adam J; Shah, Nikesh; Hu, Bei; Yin, Shen; Wu, Hao; To, Iris; Ead, Wahib S; Ashby, Joan; Janousek, Martin; Pham, Song; Wang, Jue; Kwan, Antonia; Batlevi, Connie L; Wei, Michael C; Westin, Jason

Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

对既往接受过≥2种疗法的复发或难治性滤泡性淋巴瘤患者进行莫苏妥珠单抗治疗的3年长期随访

Sehn, Laurie H; Bartlett, Nancy L; Matasar, Matthew J; Schuster, Stephen J; Assouline, Sarit E; Giri, Pratyush; Kuruvilla, John; Shadman, Mazyar; Cheah, Chan Yoon; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta J; Wei, Michael C; Yin, Shen; To, Iris; Kaufman, Derrick; Kwan, Antonia; Penuel, Elicia; Bolen, Christopher R; Budde, Lihua E

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

既往CAR-T细胞疗法对复发或难治性B细胞淋巴瘤患者接受mosunetuzumab治疗疗效的影响

Chong, Elise A; Penuel, Elicia; Napier, Ellen B; Lundberg, Rachel K; Budde, Lihua E; Shadman, Mazyar; Matasar, Matthew J; Bartlett, Nancy L; Flinn, Ian W; Bosch, Francesc; Fay, Keith; Goy, Andre; Kumar, Anita; Nastoupil, Loretta J; Wei, Michael C; Wu, Mei; Yin, Shen; Fraietta, Joseph A; Chong, Emeline R; Schuster, Stephen J

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study

在既往未接受治疗的弥漫性大B细胞淋巴瘤(DLBCL)患者中,Mosunetuzumab联合Pola-CHP方案与Pola-R-CHP方案的比较:一项2期研究的最终结果

Westin, Jason; Phillips, Tycel J; Mehta, Amitkumar; Hoffmann, Marc S; Gonzalez-Barca, Eva; Thieblemont, Catherine; Bastos-Oreiro, Mariana; Greil, Richard; Giebel, Sebastian; Wei, Michael C; Wang, Jue; Bucher, Reinhard; Sit, Jason; Penuel, Elicia; Purev, Enkhtsetseg; Yee, Donald L; Bergua-Burgues, Juan Miguel

A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma

一种提高莫苏妥珠单抗治疗复发或难治性滤泡性淋巴瘤获益风险比的新型递增剂量方案

Li, Chi-Chung; Bender, Brendan; Wilkins, Justin; Li, Feifei; Turner, David C; Wang, Bei; Deng, Rong; Vadhavkar, Shweta; Li, Zao; Kwan, Antonia; Huang, Huang; Peng, Kun; Penuel, Elicia; Huw, Ling-Yuh; Chanu, Pascal; Li, Chunze; Yin, Shen; Wei, Michael C

Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHL

托珠单抗用于治疗复发/难治性B细胞非霍奇金淋巴瘤患者中T细胞结合双特异性抗体相关细胞因子释放综合征的剂量

Jamois, Candice; Turner, David C; Gibiansky, Leonid; Li, Feifei; Menuet, Jean-Francois; Pereira, Leonardo Roque; Lundberg, Linda; Guerini, Elena; Carlile, David J; Relf, James; Wei, Michael C; Kwan, Antonia; Frey, Nicolas; Grange, Susan

Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma.

莫苏妥珠单抗在中国复发或难治性滤泡性淋巴瘤患者中的药代动力学和药效学的种族敏感性评估

Li Junyi, Liao Michael Z, Wilkins Justin, Penuel Elicia, Wang Bei, Vadhavkar Shweta, Peng Kun, Cao Junning, Li Zhiming, Zhang Ye, Li Wenjin, Li Donghang, Zhou Mingzhu, Wei Michael C, Kwan Antonia, Zhao Rong, Li Chunze, Li Chi-Chung, Turner David C

Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

莫苏妥珠单抗治疗复发/难治性惰性及侵袭性B细胞非霍奇金淋巴瘤的持久疗效:一项I/II期研究的延长随访

Budde, Lihua E; Assouline, Sarit; Sehn, Laurie H; Schuster, Stephen J; Yoon, Sung-Soo; Yoon, Dok Hyun; Matasar, Matthew J; Bosch, Francesc; Kim, Won Seog; Nastoupil, Loretta J; Flinn, Ian W; Shadman, Mazyar; Diefenbach, Catherine; Cheah, Chan Yoon; Ma, Connie Y; Huang, Huang; Kwan, Antonia; Wei, Michael C; Yin, Shen; Bartlett, Nancy L